CC BY-NC-ND 4.0 · Journal of Cardiac Critical Care TSS 2022; 06(01): 059-068
DOI: 10.1055/s-0042-1750195
Review Article

24-Hour Blood Pressure Control with Amlodipine: A Review of the Current Scenario

Tiny Nair
1   Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India
,
A Sreenivas Kumar
2   Apollo Health City Jubilee Hills, Hyderabad, Telangana
,
T Govindan Unni
3   Department of Cardiology, Jubilee Mission Medical College & Research Institute, Thrissur, Kerala, India
,
Mangesh Harihar Tiwaskar
3   Department of Cardiology, Jubilee Mission Medical College & Research Institute, Thrissur, Kerala, India
,
Shweta Sharma
4   Dr. Reddy's Laboratories, Hyderabad, Telangana, India
,
4   Dr. Reddy's Laboratories, Hyderabad, Telangana, India
› Author Affiliations
Funding None.

Abstract

Introduction Hypertension is the leading cause of cardiovascular diseases and premature death worldwide. Antihypertensive therapy using calcium channel blockers (CCBs) is one of the preferred choices to treat blood pressure (BP) and control blood pressure variability (BPV). In contrast to clinic BP, 24-hour ambulatory BP monitoring (ABPM) has evolved into an accurate and reproducible tool for the assessment and management of hypertension. Amlodipine, a longer acting dihydropyridine CCB is effective for 24 hours BP control and also minimizing BPV. The present article is the comprehensive review highlighting the efficacy of amlodipine in controlling 24-hour BP and minimizing BPV from the review of recent studies.

Materials and Methods The literature search was done using PubMed, Google Scholar, and MEDLINE databases. The studies to be included for review, were identified through the keywords: “amlodipine,” “ambulatory BP monitoring (ABPM),”“blood pressure variability (BPV),” “CCBs,” and filtering articles published in English language only.

Results Pharmacological evidence suggests that amlodipine has the ability to block all the subtypes of CCBs such as L-, N-, P-, Q-, R-, and T-type. Various clinical studies reported that amlodipine is a powerful, well-tolerated, and safe antihypertensive agent which is widely used either alone or as a key component of combination therapy for control of 24 hours BP.

Conclusion Overall, amlodipine is a proven and effective antihypertensive drug and helpful in controlling 24-hour BP, minimizing BP variability and hence reducing the risk of cardiovascular complications.

Data Availability Statement

All the relevant data have been represented in the manuscript. Any additional data can be provided by authors on reasonable request.




Publication History

Article published online:
01 June 2022

© 2022. Official Publication of The Simulation Society (TSS), accredited by International Society of Cardiovascular Ultrasound (ISCU). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India